Neo-Tango: A Neoadjuvant Study of Sequential Epirubicin+Cyclophoshamide & Paclitaxel Gemcitabine in the Treatment of High Risk Early Breast Cancer with Molecular Profiling, Proteomics & Candidate Gene Analysis.

Project Details

Short titleNeo-Tango: A Neoadjuvant Study of Sequential Epirubicin+Cyclophoshamide & Paclitaxel Gemcitabine in the Treatment of High Risk Early Breast Cancer with Molecular Profiling, Proteomics & Candidate Gene Analysis.
StatusFinished
Effective start/end date1/05/05 → 31/03/18

Funding

  • Cambridge University Hospitals NHS Foundation Trust